Jerry Rivers writes "The Globe and Mail is reporting that scientists in British Columbia have successfully used a 'decoy' molecule to shrink advanced prostate tumors. Citing a paper published in the Proceedings of the National Academy of Sciences, the the Globe story explains how the researchers are the first to find a way to block the process of androgen reception in cells and prevent, a key trigger in the onset of prostate cancer."
Researchers Use 'Decoy' Molecule to Treat Cancer
Linear Mode
